Kihara James
SEC CIK 1816160 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| ACAD | ACADIA PHARMACEUTICALS INC | Principal Accounting Off | 13.1K | — | $1.29M | 44 | 2022-02-23 | 2026-06-26 |
Most active insiders at ACAD, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Schneyer Mark C. | EVP, CFO | — | $1.13M |
| 2 | Daly James M | Dir | — | $671.1K |
| 3 | Kihara James | PRINCIPAL ACCOUNTING Off | — | $602.8K |
| 4 | Thompson Elizabeth H.Z. | EVP, Head of Research, Dev | — | $506.4K |
| 5 | Owen Adams Catherine | CEO, Dir | — | $249.9K |
| 6 | Rhodes Jennifer J | EVP, CLO, SEC | — | $245.0K |
| 7 | Ndu Adora | Dir | — | — |
| 8 | GAROFALO ELIZABETH A. | Dir | — | — |
| 9 | Poole Jonathan | Dir | — | — |
| 10 | Brege Laura | Dir | — | — |
Transactions 44
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| T | 2026-06-29 18:00 | 2026-06-26 | ACAD | ACADIA PHARMACEUTICALS INC | Kihara James | PRINCIPAL ACCOUNTING Off | S - Sale | $26.08 | -11.4K | 13.1K | -47% | -$297.9K |
| 2026-05-27 18:00 | 2026-05-26 | ACAD | ACADIA PHARMACEUTICALS INC | Kihara James | PRINCIPAL ACCOUNTING Off | S - Sale | $21.18 | -5,401 | 24.5K | -18% | -$114.4K | |
| D | 2026-05-05 18:00 | 2026-05-01 | ACAD | ACADIA PHARMACEUTICALS INC | Kihara James | PRINCIPAL ACCOUNTING Off | M - OptEx | — | +2,596 | 30.5K | +9% | — |
| D | 2026-05-05 18:00 | 2026-05-04 | ACAD | ACADIA PHARMACEUTICALS INC | Kihara James | PRINCIPAL ACCOUNTING Off | S - Sale+OE | $21.79 | -1,332 | 29.1K | -4% | -$29.0K |
| D | 2026-04-07 19:55 | 2026-04-05 | ACAD | ACADIA PHARMACEUTICALS INC | Kihara James | PRINCIPAL ACCOUNTING Off | M - OptEx | — | +2,010 | 28.9K | +7% | — |
| D | 2026-04-07 19:55 | 2026-04-07 | ACAD | ACADIA PHARMACEUTICALS INC | Kihara James | PRINCIPAL ACCOUNTING Off | S - Sale+OE | $22.20 | -1,030 | 27.9K | -4% | -$22.9K |
| DM | 2026-03-26 | 2026-03-25+ | ACAD | ACADIA PHARMACEUTICALS INC | Kihara James | PRINCIPAL ACCOUNTING Off | S - Sale+OE | $21.57 | -1,942 | 26.9K | -7% | -$41.9K |
| DM | 2026-03-26 | 2026-03-24+ | ACAD | ACADIA PHARMACEUTICALS INC | Kihara James | PRINCIPAL ACCOUNTING Off | M - OptEx | — | +3,769 | 26.7K | +16% | — |
| DM | 2025-11-19 | 2025-11-17 | ACAD | ACADIA PHARMACEUTICALS INC | Kihara James | PRINCIPAL ACCOUNTING Off | M - OptEx | — | +7,932 | 25.2K | +46% | — |
| D | 2025-11-19 | 2025-11-18 | ACAD | ACADIA PHARMACEUTICALS INC | Kihara James | PRINCIPAL ACCOUNTING Off | S - Sale+OE | $23.69 | -4,084 | 25.1K | -14% | -$96.7K |
| M | 2025-05-19 | 2025-05-16 | ACAD | ACADIA PHARMACEUTICALS INC | Kihara James | PRINCIPAL ACCOUNTING Off | S - Sale | $22.50 | -4,000 | 22.4K | -15% | -$90.0K |
| D | 2025-05-02 | 2025-05-01 | ACAD | ACADIA PHARMACEUTICALS INC | Kihara James | PRINCIPAL ACCOUNTING Off | M - OptEx | — | +2,596 | 24.9K | +12% | — |
| D | 2025-05-02 | 2025-05-02 | ACAD | ACADIA PHARMACEUTICALS INC | Kihara James | PRINCIPAL ACCOUNTING Off | S - Sale+OE | $14.60 | -1,327 | 23.5K | -5% | -$19.4K |
| D | 2025-04-08 | 2025-04-05 | ACAD | ACADIA PHARMACEUTICALS INC | Kihara James | PRINCIPAL ACCOUNTING Off | M - OptEx | — | +2,010 | 23.3K | +9% | — |
| D | 2025-04-08 | 2025-04-08 | ACAD | ACADIA PHARMACEUTICALS INC | Kihara James | PRINCIPAL ACCOUNTING Off | S - Sale+OE | $14.82 | -1,028 | 22.3K | -4% | -$15.2K |
| D | 2025-03-26 | 2025-03-26 | ACAD | ACADIA PHARMACEUTICALS INC | Kihara James | PRINCIPAL ACCOUNTING Off | S - Sale+OE | $17.05 | -1,095 | 21.3K | -5% | -$18.7K |
| D | 2025-03-26 | 2025-03-25 | ACAD | ACADIA PHARMACEUTICALS INC | Kihara James | PRINCIPAL ACCOUNTING Off | M - OptEx | — | +2,142 | 22.4K | +11% | — |
| D | 2025-02-25 | 2025-02-23 | ACAD | ACADIA PHARMACEUTICALS INC | Kihara James | PRINCIPAL ACCOUNTING Off | M - OptEx | — | +840 | 20.7K | +4% | — |
| D | 2025-02-25 | 2025-02-24 | ACAD | ACADIA PHARMACEUTICALS INC | Kihara James | PRINCIPAL ACCOUNTING Off | S - Sale+OE | $19.96 | -475 | 20.2K | -2% | -$9,481 |
| DM | 2024-11-19 | 2024-11-17 | ACAD | ACADIA PHARMACEUTICALS INC | Kihara James | PRINCIPAL ACCOUNTING Off | M - OptEx | — | +7,930 | 20.0K | +66% | — |
| D | 2024-11-19 | 2024-11-19 | ACAD | ACADIA PHARMACEUTICALS INC | Kihara James | PRINCIPAL ACCOUNTING Off | S - Sale+OE | $16.81 | -4,073 | 19.9K | -17% | -$68.5K |
| D | 2024-05-03 | 2024-05-02 | ACAD | ACADIA PHARMACEUTICALS INC | Kihara James | PRINCIPAL ACCOUNTING Off | S - Sale+OE | $16.94 | -1,326 | 14.4K | -8% | -$22.5K |
| D | 2024-05-03 | 2024-05-01 | ACAD | ACADIA PHARMACEUTICALS INC | Kihara James | PRINCIPAL ACCOUNTING Off | M - OptEx | — | +2,596 | 15.7K | +20% | — |
| DM | 2024-04-09 | 2024-04-08 | ACAD | ACADIA PHARMACEUTICALS INC | Kihara James | PRINCIPAL ACCOUNTING Off | S - Sale+OE | $17.87 | -1,790 | 13.9K | -11% | -$32.0K |
| DM | 2024-04-09 | 2024-04-05+ | ACAD | ACADIA PHARMACEUTICALS INC | Kihara James | PRINCIPAL ACCOUNTING Off | M - OptEx | — | +3,499 | 14.9K | +31% | — |
| D | 2024-02-27 | 2024-02-26 | ACAD | ACADIA PHARMACEUTICALS INC | Kihara James | PRINCIPAL ACCOUNTING Off | S - Sale+OE | $24.67 | -474 | 11.4K | -4% | -$11.7K |
| D | 2024-02-27 | 2024-02-23 | ACAD | ACADIA PHARMACEUTICALS INC | Kihara James | PRINCIPAL ACCOUNTING Off | M - OptEx | — | +840 | 11.9K | +8% | — |
| 2023-12-15 | 2023-12-15 | ACAD | ACADIA PHARMACEUTICALS INC | Kihara James | Principal Accounting Off | S - Sale | $28.30 | -2,000 | 11.0K | -15% | -$56.6K | |
| DM | 2023-11-21 | 2023-11-17 | ACAD | ACADIA PHARMACEUTICALS INC | Kihara James | Principal Accounting Off | M - OptEx | — | +3,964 | 13.0K | +44% | — |
| D | 2023-11-21 | 2023-11-20 | ACAD | ACADIA PHARMACEUTICALS INC | Kihara James | Principal Accounting Off | S - Sale+OE | $22.64 | -1,985 | 13.0K | -13% | -$44.9K |
| 2023-09-19 | 2023-09-15 | ACAD | ACADIA PHARMACEUTICALS INC | Kihara James | Principal Accounting Off | S - Sale | $25.88 | -2,000 | 10.8K | -16% | -$51.8K | |
| 2023-06-16 | 2023-06-15 | ACAD | ACADIA PHARMACEUTICALS INC | Kihara James | Principal Accounting Off | S - Sale | $24.15 | -2,000 | 9,144 | -18% | -$48.3K | |
| DM | 2023-05-19 | 2023-05-17 | ACAD | ACADIA PHARMACEUTICALS INC | Kihara James | Principal Accounting Off | M - OptEx | — | +11.9K | 11.1K | New | — |
| D | 2023-05-19 | 2023-05-17 | ACAD | ACADIA PHARMACEUTICALS INC | Kihara James | Principal Accounting Off | S - Sale+OE | $22.50 | -5,947 | 11.1K | -35% | -$133.8K |
| D | 2023-04-11 | 2023-04-10 | ACAD | ACADIA PHARMACEUTICALS INC | Kihara James | Principal Accounting Off | S - Sale+OE | $18.14 | -523 | 5,197 | -9% | -$9,487 |
| D | 2023-04-11 | 2023-04-07 | ACAD | ACADIA PHARMACEUTICALS INC | Kihara James | Principal Accounting Off | M - OptEx | — | +1,489 | 5,720 | +35% | — |
| D | 2023-04-07 | 2023-04-06 | ACAD | ACADIA PHARMACEUTICALS INC | Kihara James | Principal Accounting Off | S - Sale+OE | $18.16 | -701 | 4,231 | -14% | -$12.7K |
| D | 2023-04-07 | 2023-04-05 | ACAD | ACADIA PHARMACEUTICALS INC | Kihara James | Principal Accounting Off | M - OptEx | — | +2,009 | 4,932 | +69% | — |
| D | 2023-02-27 | 2023-02-24 | ACAD | ACADIA PHARMACEUTICALS INC | Kihara James | Principal Accounting Off | S - Sale+OE | $18.78 | -350 | 2,923 | -11% | -$6,573 |
| D | 2023-02-27 | 2023-02-23 | ACAD | ACADIA PHARMACEUTICALS INC | Kihara James | Principal Accounting Off | M - OptEx | — | +840 | 3,273 | +35% | — |
| D | 2022-04-11 | 2022-04-07 | ACAD | ACADIA PHARMACEUTICALS INC | Kihara James | Principal Accounting Off | M - OptEx | — | +2,977 | 3,458 | +619% | — |
| D | 2022-04-11 | 2022-04-08 | ACAD | ACADIA PHARMACEUTICALS INC | Kihara James | Principal Accounting Off | S - Sale+OE | $27.05 | -1,025 | 2,433 | -30% | -$27.7K |
| D | 2022-02-25 | 2022-02-23 | ACAD | ACADIA PHARMACEUTICALS INC | Kihara James | Principal Accounting Off | S - Sale+OE | $23.80 | -359 | 481 | -43% | -$8,544 |
| D | 2022-02-25 | 2022-02-23 | ACAD | ACADIA PHARMACEUTICALS INC | Kihara James | Principal Accounting Off | M - OptEx | $0.00 | +840 | 840 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations